Metagenomi, Inc. (MGX)
NASDAQ:MGX
US Market
Holding MGX?
Track your performance easily

Metagenomi, Inc. (MGX) Financial Statements

44 Followers

Metagenomi, Inc. Financial Overview

Metagenomi, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.52; its P/E ratio is -0.78; Metagenomi, Inc. is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Dec 22Dec 21
Income Statement-
Total Revenue$ 20.01M---
Gross Profit$ 20.01M---
EBIT$ -12.94M---
EBITDA$ -11.71M---
Net Income Common Stockholders$ -10.74M---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 299.92M$ 292.93M$ 362.13M$ 108.15M
Total Assets$ 385.90M$ 386.43M$ 414.49M$ 172.27M
Total Debt$ 47.94M$ 48.21M$ 18.57M$ 18.65M
Net Debt$ -251.98M$ -244.72M$ -343.56M$ -89.50M
Total Liabilities$ 116.49M$ 154.70M$ 142.81M$ 67.77M
Stockholders Equity$ 269.42M$ 231.74M$ 271.68M$ 43.95M
Cash Flow-
Free Cash Flow$ -26.97M---
Operating Cash Flow$ -26.31M---
Investing Cash Flow$ -13.04M---
Financing Cash Flow$ -2.03M---
Currency in USD

Metagenomi, Inc. Earnings and Revenue History

Metagenomi, Inc. Debt to Assets

Metagenomi, Inc. Cash Flow

Metagenomi, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis